|
Volumn 64, Issue 3, 2003, Pages 265-276
|
Determining and achieving therapeutic targets in attention-deficit/hyperactivity disorder.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CENTRAL STIMULANT AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
ADOLESCENT;
ADULT;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
CHILD;
CLINICAL TRIAL;
CONFERENCE PAPER;
HUMAN;
NOMENCLATURE;
PREVALENCE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BEHAVIOR THERAPY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
CLINICAL TRIALS;
HUMANS;
PREVALENCE;
TERMINOLOGY;
TREATMENT OUTCOME;
|
EID: 0038700760
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v64n0307 Document Type: Conference Paper |
Times cited : (4)
|
References (0)
|